Bionomics Ltd share price logo

Bionomics Ltd Share Price

NASDAQ: NEUP

Small Cap

$15.30

+0.13

(+0.86%)

as on

Bionomics Ltd Stock Performance

as on October 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $14.81
    $16.4
    downward going graph

    3.20%

    Downside

    7.19%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.9
    $21.4
    downward going graph

    81.05%

    Downside

    39.87%

    Upside

    downward going graph

Bionomics Ltd share price movements today

Previous Close
$15.17
Open
$15.21
Volume
199.1K
Day's Low - High
$14.81 - $16.4
52 Week Low - High
$2.9 - $21.4

Bionomics Ltd Historical Returns

1 Month Return
+ 65.11 %
3 Month Return
+ 108.32 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Bionomics Ltd Stock Fundamentals & Key Indicators

Check Bionomics Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$96.5M

EPS (TTM)

-1.85

Dividend Yield

0.00%

PE Ratio (TTM)

0.45

Industry PE ratio

0

PEG Ratio

0

Return On Equity TTM

0.00%

Bionomics Ltd Stock Valuation

Track how Bionomics Ltd P/E has moved over time to understand its valuation trends.

Bionomics Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-0.16x)

March 31, 2025

Industry (0.00x)

October 18, 2025

Today (0.45x)

October 18, 2025

Highest (-0.04x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 0.45x

Bionomics Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bionomics Ltd with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Bionomics Ltd image
Bionomics Ltd
NA$96.5MNA0.450.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$63.1B231.27%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$36.7BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$104.8B91.13%29.0431.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$60.3B-3.62%14.3531.37%

Bionomics Ltd Stock’s Investor Sentiment and Interest

Search interest for Bionomics Ltd Stock has increased by 16% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:16% versus previous 30 day period

Bionomics Ltd Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
-
-
0
15
-15
Gross Profit
-
-
0
0
0
0
14
-15
Operating Income
-5
-4
-2
-5
-3
-3
11
-1,133
EBITDA
-5
-4
-2
-5
0
-3
11
-1,136
Interest Expense
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
-
Income Before Tax
-5
-4
-2
-2
0
-1
11
-846
Income Tax Expense
0
0
0
0
0
0
0
-468
Net Income
-5
-4
-2
-2
0
-1
11
-378
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-293.24%
75.08%
2414.30%

Bionomics Ltd Annual Profit & Loss

All numbers in Millions USD

Jun 2016
Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Total Revenue
5
4
2
2
0
0
6
-
-
Gross Profit
-5
2
-13
-4
-2
-3
-9
-
-
Operating Income
-21
-10
-21
-10
-6
-16
-33
-21
-17
EBITDA
-11
-3
-17
-5
-1
-4
-14
-20
-17
Interest Expense
1
1
1
1
1
1
0
0
-
Depreciation
-
-
-
-
-
1
0
0
0
Income Before Tax
-12
-4
-19
-6
-4
-8
-21
-21
-15
Income Tax Expense
0
0
0
0
0
0
0
0
0
Net Income
-12
-5
-18
-6
-4
-4
-14
-14
-15
Net Profit Margin
-237.84%
-125.56%
-668.33%
-252.83%
-15255.18%
-704.08%
-247.20%
0.00%
0.00%

Bionomics Ltd Quarterly Cash Flow

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Net Income
-
-
-5
-4
-2
-2
0
-1
11
Operating Cash Flow
-5
-
-4
-3
-3
-3
-4
-3
11
Investing Cash Flow
-
0
-
-
-
-
-
-
-
Financing Cash Flow
0
0
0
5
1
7
0
0
1
Change in Cash
-5
-2
-3
2
-1
4
-4
-3
12

Bionomics Ltd Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Net Income
-
-
-
-4
-6
-14
-21
-15
-369
Operating Cash Flow
-1
-15
-10
-2
-5
-14
-14
-14
77
Investing Cash Flow
0
0
0
0
0
0
0
-
-
Financing Cash Flow
-1
1
3
-3
23
18
3
15
1,528
Change in Cash
-2
-13
-7
-6
17
3
-15
0
1,601

Insights on Bionomics Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, NEUP stock has moved down by -11.3%

About Bionomics Ltd

Neuphoria Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need. Its lead drug candidate, BNC210, is an oral, proprietary, selective negative allosteric modulator of the α7 nicotinic acetylcholine receptor, for the acute, as-needed treatment of social anxiety disorder and for the chronic treatment of post-traumatic stress disorder. BNC210 is a well-tolerated, broad-spectrum antianxiety experimental therapeutic, designed to restore neurotransmitter balance in relevant brain areas, providing rapid relief from stress and anxiety symptoms without the common pitfalls of sedation, cognitive impairment, or addiction. In addition, the Company has two drugs in early-stage clinical trials for the treatment of cognitive deficits in Alzheimer’s disease and other central nervous system conditions.
OrganisationBionomics Ltd
Headquarters100 Summit Drive, Burlington, MA, United States, 01803
CEODr. Spyridon Papapetropoulos M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Bionomics Ltd

Name

Title

Dr. Julie Kerner Ph.D.

Senior Vice President of Business Operations

Dr. Mark A. Smith M.D., Ph.D.

Chief Medical Officer

Mr. Adrian Hinton BEC, F.C.A.

Financial Controller

Mr. Rajeev Chandra B.Com., C.A., M.B.A.

Company Secretary

Dr. Spyridon Papapetropoulos M.D., Ph.D.

CEO, President & Executive Director

Ms. Elizabeth Doolin M.Sc.

Senior Vice President of Clinical Development

FAQs

What is Bionomics Ltd share price today?

Bionomics Ltd share price today is $15.3 as on at the close of the market. Bionomics Ltd share today touched a day high of $16.4 and a low of $14.81.

What is the 52 week high and 52 week low for Bionomics Ltd share?

Bionomics Ltd share touched a 52 week high of $21.4 on and a 52 week low of $2.9 on . Bionomics Ltd stock price today i.e. is closed at $15.3,which is 28.51% down from its 52 week high and 427.59% up from its 52 week low.

What is Bionomics Ltd's market capitalisation today?

Bionomics Ltd market capitalisation is $0.00T as on .

How to invest in Bionomics Ltd Stock (NEUP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bionomics Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bionomics Ltd Shares that will get you 0.0980 shares as per Bionomics Ltd share price of $15.3 per share as on October 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Bionomics Ltd Stock (NEUP) from India?

Indian investors can start investing in Bionomics Ltd (NEUP) shares with as little as ₹87.954 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.54 in Bionomics Ltd stock (as per the Rupee-Dollar exchange rate as on ). Based on Bionomics Ltd share’s latest price of $15.3 as on October 18, 2025 at 1:29 am IST, you will get 0.6536 shares of Bionomics Ltd. Learn more about fractional shares .